Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine with hydromorphone versus sufentanil for labor epidural analgesia and maternal intrapartum temperature
ChiCTR2200064209Phase 4Not yet recruiting
- Sponsor
- Nanjing Maternal and Child Health Hospital
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydromorphone, sufentanil and ropivacaine in fever and labor pain (2 arms), sponsored by Nanjing Maternal and Child Health Hospital. Primary endpoint: Incidence of epidural-related intrapartum fever. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
hydromorphonesufentanilropivacaine
03
Conditions
feverlabor pain
Beyond the preview
Go deeper on ChiCTR2200064209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064209.